Evidence-Based Myopia Management – Clinical Implications of the New Standard of Care

Myopia is thought to be a modifiable risk factor for the development of eye disease and vision loss.

As a result, alleviating Myopia symptoms with spectacles or contact lenses is no longer considered sufficient. The World Council of Optometry, the European Society of Ophthalmology, and the International Myopia Institute have recently called for an evolution in the standard of care for Myopia management.

James Loughman is the Clinical Research Director for Ocuco Ltd.

An Optometrist with more than 20 years of clinical, academic, research and management experience, James recently joined Ocuco as Clinical Research Director. James is also presently the Director of the Centre for Eye Research Ireland, a research facility based in the Dublin Institute of Technology, the same university where he received his PhD in 1997; James oversees a portfolio of research including technology development and big data analytics projects alongside various clinical trials for the control of myopia, glaucoma and other blinding conditions.